| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| NMN | Acute Pancreatitis | 1 | PM | 36321732 | 📋 | Gut microbiota-derived nicotinamide mononucleotide alleviates acute pancreatitis by activating pancreatic SIRT3 signalling |
| NMN | Aging Liver | 1 | PM | 35931320 | 📋 | Quantitative Acetylomics Reveals Dynamics of Protein Lysine Acetylation in Mouse Livers During Aging and Upon the Treatment of Nicotinamide Mononucleotide |
| NMN | Colitis | 1 | PM | 35063804 | 📋 | NAMPT mitigates colitis severity by supporting redox-sensitive activation of phagocytosis in inflammatory macrophages |
| NMN | Dysbiosis | 3 | PM | 37447318 | 📋 | NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota |
| NMN | Dysbiosis | 2 | PM | 37271037 | 📋 | Nicotinamide mononucleotide improves the Alzheimer's disease by regulating intestinal microbiota |
| NMN | Dysbiosis | 1 | PM | 34395502 | 📋 | NMN Maintains Intestinal Homeostasis by Regulating the Gut Microbiota |
| NMN | Gastric Motility Disorders | 1 | PM | 29263919 | 📋 | Nicotinamide adenine dinucleotide replenishment rescues colon degeneration in aged mice |
| NMN | Gastrointestinal Disorders | 1 | PM | 35678708 | 📋 | Nicotinamide mononucleotide supplementation protects the intestinal function in aging mice and D-galactose induced senescent cells |
| NMN | Hepatic Fibrosis | 1 | PM | 33220424 | 📋 | Nicotinamide Mononucleotide Inhibits Hepatic Stellate Cell Activation to Prevent Liver Fibrosis via Promoting PGE 2 Degradation |
| NMN | Hepatic Steatosis | 2 | PM | 38703507 | 📋 | Alleviation of hepatic insulin resistance and steatosis with NMN via improving endoplasmic reticulum-Mitochondria miscommunication in the liver of HFD mice |
| NMN | Hepatic Steatosis | 1 | PM | 34752167 | 📋 | NAMPT-mediated NAD+ biosynthesis suppresses activation of hepatic stellate cells and protects against CCl4-induced liver fibrosis in mice |
| NMN | Inflammatory Bowel Disease | 2 | PM | 37447318 | 📋 | NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota |
| NMN | Inflammatory Bowel Disease | 1 | PM | 36105890 | 📋 | Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota |
| NMN | Inflammatory Bowel Disease | 3 | PM | 35063804 | 📋 | NAMPT mitigates colitis severity by supporting redox-sensitive activation of phagocytosis in inflammatory macrophages |
| NMN | Intestinal Permeability | 3 | PM | 37447318 | 📋 | NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota |
| NMN | Intestinal Permeability | 2 | PM | 36105890 | 📋 | Treatment of inflammatory bowel disease: Potential effect of NMN on intestinal barrier and gut microbiota |
| NMN | Intestinal Permeability | 1 | PM | 34395502 | 📋 | NMN Maintains Intestinal Homeostasis by Regulating the Gut Microbiota |
| NMN | Liver Cancer | 2 | PM | 38197493 | 📋 | Nicotinamide mononucleotide induces autophagy and ferroptosis via AMPK/mTOR pathway in hepatocellular carcinoma |
| NMN | Liver Cancer | 1 | PM | 35815363 | 📋 | NAD + salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity |
| NMN | Liver Damage | 1 | PM | 35699728 | 📋 | Nicotinamide Mononucleotide Administration Restores Redox Homeostasis via the Sirt3-Nrf2 Axis and Protects Aged Mice from Oxidative Stress-Induced Liver Injury |
| NMN | Liver Disease | 1 | PM | 35626691 | 📋 | Nicotinamide Mononucleotide Administration Amends Protein Acetylome of Aged Mouse Liver |
| NMN | MAFLD | 2 | PM | 38729053 | 📋 | Integrated transcriptome and metabolome study reveal the therapeutic effects of nicotinamide riboside and nicotinamide mononucleotide on nonalcoholic fatty liver disease |
| NMN | MAFLD | 1 | PM | 33932956 | 📋 | NAD + and NAFLD - Caution, Causality, and Careful Optimism |
